Abstract |
This study examined whether pathological findings were present in cochlear vessels for patients with diabetes mellitus. Twenty-six temporal bones from 13 patients with type 1 diabetes mellitus and 40 temporal bones from 20 patients with type 2 diabetes mellitus were examined. Type 2 diabetic temporal bones were divided into 2 groups according to diabetic management (22 temporal bones with insulin therapy, and 18 with oral hypoglycemic drugs). Age-matched normal control temporal bones were also selected. The vessel wall thickness in the cochlear spiral modiolar artery was measured under a light microscope, and the vessel wall ratio (vessel wall thickness/outer diameter of the vessel x 100) was calculated. The vessel wall thickness and vessel wall ratio in type 1 diabetes mellitus were significantly greater than in normal controls. Type 2 diabetic patients with insulin therapy showed significantly greater vessel wall thickness and vessel wall ratios than controls. In type 2 diabetes mellitus, the vessel wall thickness and vessel wall ratio were greater in patients treated with insulin therapy than in those treated with oral hypoglycemic agents. Type 2 diabetic patients with insulin therapy showed an increased vessel wall thickness and vessel wall ratio compared to patients with type 1 diabetes mellitus. In conclusion, the cochlea in patients with diabetes mellitus shows circulatory disturbance compared to age-matched normal controls.
|
Authors | Shin Kariya, Sebahattin Cureoglu, Hisaki Fukushima, Norimasa Morita, Muzeyyen Y Baylan, Yukihide Maeda, Kazunori Nishizaki, Michael M Paparella |
Journal | Acta medica Okayama
(Acta Med Okayama)
Vol. 64
Issue 6
Pg. 375-83
(Dec 2010)
ISSN: 0386-300X [Print] Japan |
PMID | 21173807
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hypoglycemic Agents
- Insulin
|
Topics |
- Adolescent
- Adult
- Aged
- Arteries
(pathology)
- Case-Control Studies
- Child
- Cochlea
(blood supply)
- Diabetes Mellitus, Type 1
(drug therapy, pathology)
- Diabetes Mellitus, Type 2
(drug therapy, pathology)
- Female
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Insulin
(therapeutic use)
- Male
- Middle Aged
- Temporal Bone
(pathology)
- Young Adult
|